Doximity, Inc. (DOCS) News

Doximity, Inc. (DOCS): $33.99

1.84 (+5.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter DOCS News Items

DOCS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DOCS News Highlights

  • For DOCS, its 30 day story count is now at 65.
  • Over the past 17 days, the trend for DOCS's stories per day has been choppy and unclear. It has oscillated between 1 and 14.
  • ROSE, PAY and GDS are the most mentioned tickers in articles about DOCS.

Latest DOCS News From Around the Web

Below are the latest news stories about DOXIMITY INC that investors may wish to consider to help them evaluate DOCS as an investment opportunity.

Doximity: There''s Much To Be Excited About Here (NYSE:DOCS)

Doximity has seen its revenue growth rates stabilize, while it remains highly profitable. Click here to find out why DOCS is a Buy.

Seeking Alpha | November 24, 2022

Is Doximity''s Stock Still Too Expensive to Buy?

The stock still trades at close to 50 times earnings.

The Motley Fool | November 23, 2022

Is Doximity's Stock Still Too Expensive to Buy?

Ever since Doximity (NYSE: DOCS) went public in June 2021, the stock has been commanding a significant premium. Unsurprisingly, as investors have become more focused on valuations and earnings multiples, shares of Doximity have been falling in value and are down 38% year to date. Investors may be wondering if this has created a buying opportunity for a business that still sees plenty of growth in its future.

Yahoo | November 23, 2022

A closer look at Doximity Inc. (DOCS) is warranted

Doximity Inc. (NYSE:DOCS) closed Monday at $31.16 per share, down from $31.70 a day earlier. While Doximity Inc. has underperformed by -1.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DOCS fell by -49.09%, with highs and lows ranging from $68.94 to $22.91, whereas the simple […]

US Post News | November 22, 2022

Why I Own Doximity Stock

The online platform for physicians could 10x over the next 10 years.

The Motley Fool | November 21, 2022

2 Unstoppable Growth Stocks to Buy Now and Hold Forever

A topsy-turvy stock market isn't going to knock these growth stocks off of their upward-sloping paths forward.

Yahoo | November 20, 2022

3 Beaten-Down Growth Stocks You Can Buy Now With Just $200

Most investors would answer yes, but that doesn't mean we can afford to go all in on the most popular growth stocks of the day. Fiverr International (NYSE: FVRR) was a stock market darling in the early days of the COVID-19 pandemic. Fiverr is an important member of the growing gig economy.

Yahoo | November 19, 2022

Doximity''s Free Cash Flow Just More Than Doubled From a Year Ago -- Is the Stock a Buy?

The digital platform for doctors has always focused on profitable growth, and it''s really starting to pay off.

The Motley Fool | November 17, 2022

Doximity's Free Cash Flow Just More Than Doubled From a Year Ago -- Is the Stock a Buy?

The digital platform for doctors has always focused on profitable growth, and it's really starting to pay off.

Yahoo | November 17, 2022

Doximity Inc. (DOCS) deserves closer scrutiny

The share price of Doximity Inc. (NYSE:DOCS) rose to $32.78 per share on Tuesday from $30.95. While Doximity Inc. has overperformed by 5.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DOCS fell by -53.68%, with highs and lows ranging from $72.60 to $22.91, whereas the […]

US Post News | November 16, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5265 seconds.